Cost-effectiveness of laser Doppler imaging in burn care in the Netherlands

被引:17
|
作者
Hop, M. Jenda [1 ,2 ]
Hiddingh, Jakob [1 ,3 ]
Stekelenburg, Carlijn [1 ,4 ]
Kuipers, Hester C. [1 ,3 ]
Middelkoop, Esther [1 ,4 ,5 ]
Nieuwenhuis, Marianne K. [1 ,3 ]
Polinder, Suzanne [6 ]
van Baar, Margriet E. [1 ,2 ]
机构
[1] Red Cross Hosp, Assoc Dutch Burn Ctr, Beverwijk, Netherlands
[2] Maasstad Hosp, Burn Ctr, Rotterdam, Netherlands
[3] Martini Hosp, Burn Ctr, Groningen, Netherlands
[4] Red Cross Hosp, Burn Ctr, Beverwijk, Netherlands
[5] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands
[6] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
来源
BMC SURGERY | 2013年 / 13卷
关键词
Laser doppler imaging; Burns; Diagnosis; Cost-effectiveness analysis; QUALITY-OF-LIFE; DEPTH; RELIABILITY; ACCURACY; PATIENT; EUROQOL; IMPACT; SCARS; METER;
D O I
10.1186/1471-2482-13-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Early accurate assessment of burn depth is important to determine the optimal treatment of burns. The method most used to determine burn depth is clinical assessment, which is the least expensive, but not the most accurate. Laser Doppler imaging (LDI) is a technique with which a more accurate (>95%) estimate of burn depth can be made by measuring the dermal perfusion. The actual effect on therapeutic decisions, clinical outcomes and the costs of the introduction of this device, however, are unknown. Before we decide to implement LDI in Dutch burn care, a study on the effectiveness and cost-effectiveness of LDI is necessary. Methods/design: A multicenter randomised controlled trial will be conducted in the Dutch burn centres: Beverwijk, Groningen and Rotterdam. All patients treated as outpatient or admitted to a burn centre within 5 days post burn, with burns of indeterminate depth (burns not obviously superficial or full thickness) and a total body surface area burned of <= 20% are eligible. A total of 200 patients will be included. Burn depth will be diagnosed by both clinical assessment and laser Doppler imaging between 2-5 days post burn in all patients. Subsequently, patients are randomly divided in two groups: 'new diagnostic strategy' versus 'current diagnostic strategy'. The results of the LDI-scan will only be provided to the treating clinician in the 'new diagnostic strategy' group. The main endpoint is the effect of LDI on wound healing time. In addition we measure: a) the effect of LDI on other patient outcomes (quality of life, scar quality), b) the effect of LDI on diagnostic and therapeutic decisions, and c) the effect of LDI on total (medical and non-medical) costs and cost-effectiveness. Discussion: This trial will contribute to our current knowledge on the use of LDI in burn care and will provide evidence on its cost-effectiveness.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Cost-effectiveness of targeted screening for hepatitis C in The Netherlands
    Helsper, C. W.
    Borkent-Raven, B. A.
    De Wit, N. J.
    Van Essen, G. A.
    Bonten, M. J. M.
    Hoepelman, A. I. M.
    Janssen, M. P.
    De Wit, G. A.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (01): : 58 - 69
  • [42] Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    Habbema, J. Dik F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15): : 1083 - 1092
  • [43] Cost-effectiveness of influenza vaccination for healthy adults in the Netherlands
    Meijboom, M. J.
    Hak, E.
    Jansen, A. G.
    Sanders, E. A.
    Buskens, E.
    VALUE IN HEALTH, 2007, 10 (06) : A442 - A442
  • [44] Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands
    I. Lenoir-Wijnkoop
    W. M. C. van Aalderen
    G. Boehm
    D. Klaassen
    A. B. Sprikkelman
    M. J. C. Nuijten
    The European Journal of Health Economics, 2012, 13 : 101 - 110
  • [45] COST-EFFECTIVENESS OF TARGETED SCREENING FOR HEPATITIS C IN THE NETHERLANDS
    Helsper, C. W.
    Borkent-Raven, B. A.
    de Wit, N. J.
    van Essen, G. A.
    Bonten, M.
    Janssen, M. P.
    Hoepelman, I
    De Wit, G. A.
    VALUE IN HEALTH, 2009, 12 (07) : A429 - A429
  • [46] Cost-effectiveness of additional blood screening tests in the Netherlands
    Borkent-Raven, Barbara A.
    Janssen, Mart P.
    van der Poel, Cees L.
    Bonsel, Gouke J.
    van Hout, Ben A.
    TRANSFUSION, 2012, 52 (03) : 478 - 488
  • [47] COST-EFFECTIVENESS OF UNIVERSAL VACCINATION AGAINST VARICELLA IN THE NETHERLANDS
    de Boer, P. T.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A357 - A357
  • [48] Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
    Nuijten, Mark J. C.
    Dubois, Dominique J.
    Joseph, Alain
    Annemans, Lieven
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [49] Cost-effectiveness of mass vaccination with a rotavirus vaccine in the Netherlands
    Al, M. J.
    Goossens, L.
    Hovels, A. M.
    Michielsen, C. P.
    Standaert, B. A.
    VALUE IN HEALTH, 2006, 9 (06) : A304 - A304
  • [50] Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands
    Blommestein, Hedwig M.
    de Groot, Saskia
    Aarts, Mieke J.
    Vemer, Pepijn
    de Vries, Robin
    van Abeelen, Annet F. M.
    Posthuma, E. F. M. Ward
    Uyl-de Groota, Carin A.
    LEUKEMIA RESEARCH, 2016, 50 : 37 - 45